Source: MarketScreener

Triplet Therapeutics: Triplet Therapeutics to Present at Stifel Virtual Healthcare Conference

(marketscreener.com) Triplet Therapeutics, Inc., a biotechnology company leveraging insights from the human genetics of repeat expansion disorders , today announced that Nessan Bermingham, Ph.D., Triplet's chief executive officer, president, and founder, will present at the Stifel Virtual Healthcare Conference taking place November 16-18, 2020. Dr. Bermingham...https://www.marketscreener.com/news/latest/Triplet-Therapeutics-to-Present-at-Stifel-Virtual-Healthcare-Conference--31790700/?utm_medium=RSS&utm_content=20201116

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
100-250
Nessan Bermingham's photo - Chairman & CEO of TRIPLET

Chairman & CEO

Nessan Bermingham

CEO Approval Rating

87/100

Read more